Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actemra in severe COVID-19
NCT04412772Phase 3Terminated
- Sponsor
- The Queen's Medical Center
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in coronavirus disease 2019 (COVID-19), sponsored by The Queen's Medical Center. Started Jun 2020; status: terminated.
02
Drugs
tocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04412772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412772.